Lidanserin (INN; ZK-33,839) is a drug which acts as a combined 5-HT2A and α1-adrenergic receptor antagonist.

[1] It was developed as an antihypertensive agent but was never marketed.

[1] This drug article relating to the nervous system is a stub.

You can help Wikipedia by expanding it.